🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Enovis Corporation

ENOV Healthcare
$20.98 $-0.82 (-3.76%)
Market Cap: $1.21 B
Gurus Holding
6
Popularity Rank
#1527
% of Shares Held
2.00%
Net Activity (Q1 2026)
-$55.62 M

Guru Ownership Trend

Guru Analysis for Enovis Corporation (ENOV)

Enovis Corporation (ENOV), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $24.2 M.

Top institutional holders include Chuck Royce and Cliff Asness.

Institutional sentiment is currently Bearish. This is evidenced by a $55.62 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 499.4%. Conversely, Chuck Royce reduced exposure by 26.1%.

Key Holders

Top 5 by Value

$13.9 M
$6.46 M
$1.17 M
$1.01 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$10 M
Total Buy Value
New Buys 2
Additions 2
-$65.63 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
2
Net Buyers
4

FAQs for Enovis Corporation (ENOV)

Major holders include Chuck Royce ($13.9 M), Cliff Asness ($6.46 M), Paul Tudor Jones ($3.39 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.15 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $55.62 M, with 4 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ENOV. The total reported sell value was $65.63 M.

Yes, 2 managers opened new positions in ENOV, and 2 increased their existing holdings. The total reported buy value was $10 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% Reduce -26.1% 611,090 $13.9 M Q1 2026
0.00% Add 499.4% 283,912 $6.46 M Q1 2026
0.01% New Buy 148,931 $3.39 M Q1 2026
0.01% New Buy 51,224 $1.17 M Q1 2026
0.05% 44,258 $1.01 M Q1 2026
0.00% Add 27.1% 14,067 $320,024 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form